Infleqtion Lands $55 Million Quantum Contract as Citron Calls It the Most Mispriced Stock
NEW YORK, April 19 —
Infleqtion (INFQ) hit an all-time high after winning a $55M contract and drawing a rare bullish call from Citron Research.
- Infleqtion secured a $55M contract as a key quantum supplier — nearly 2x its $32mn in trailing twelve-month revenue
- Forward P/E sits at -114.3x; the company is burning cash with no breakeven in sight
- Next catalyst: upcoming 13F filings will reveal whether institutional money backed Citron's thesis or whether this remains a retail-driven trade
What Actually Happened
Two things landed at once. Together, they matter more than either one alone. The $55M contract establishes Infleqtion as a working supplier in the quantum stack — not a research-stage company pitching slide decks. A contract worth 1.7x your trailing twelve-month revenue is material by any definition.
Then Citron Research weighed in. The firm, best known for short-selling campaigns that sank stocks from Valeant to GameStop, publicly called INFQ the most obvious mispricing in quantum. That is a sharp turn for a shop whose reputation rests on spotting overvaluation, not undervaluation. When the loudest short-seller in the room goes long on the most speculative part of your sector, retail traders notice. They did.
The Catch
A $55M contract looks large against $32mn in TTM revenue. But the details are missing, and they matter. Who is the customer? Over how many years does $55M get recognized? A five-year deal works out to $11M annually — solid growth, not transformational. A two-year deal changes the math entirely.
The forward P/E of -114.3x is not a misprint. Infleqtion is deeply unprofitable, priced entirely on the bet that quantum computing's commercial moment is close. Citron's endorsement moves sentiment, not fundamentals. The firm does not manage a fund. It publishes research. The real test is whether large institutions add INFQ in the next round of 13F disclosures.
Bottom Line
Infleqtion has a better story today than it did last week. A real contract plus a high-profile endorsement is more substance than most quantum names can claim. But at $17.42 on $32mn in revenue and no path to near-term profitability, buyers are paying for a narrative, not a business. The stock's next move hinges on whether the $55M contract's details justify the current price — or reveal a slower revenue ramp than traders assumed.
Infleqtion does not yet have a Basis Report. Generate a full INFQ investment report here to dig into the financials beyond the headline.
Basis Report does not hold positions in securities discussed. This is not investment advice.